Intravitreal Eye Injections in Sarasota, FL

Eye injections are used to deliver medication directly into the back of the eye to treat retinal diseases. They are most commonly used to manage conditions such as wet macular degeneration, diabetic retinopathy, diabetic macular edema, and retinal vein occlusion.

These injections help reduce swelling, stop abnormal blood vessel growth, and prevent further vision loss. In many cases, they can stabilize or even improve vision when given consistently.

By placing medication directly where it is needed, intravitreal injections provide a highly targeted and effective form of treatment.

An intravitreal injection is a procedure in which medication is injected directly into the vitreous cavity, the gel-filled space in the center of the eye. This allows the medication to reach the retina and macula at therapeutic levels.

The word “intravitreal” simply means “inside the vitreous.” By delivering medication directly into the eye, retina specialists can treat conditions such as wet macular degeneration, diabetic retinopathy, retinal vein occlusion, and geographic atrophy more effectively than with pills or eye drops.

The procedure is performed in the office under sterile conditions. The eye is numbed with anesthetic drops, cleaned with antiseptic, and the injection itself takes only a few seconds. Most patients feel pressure rather than pain.

Intravitreal injections are a major advance in modern retina care and have helped prevent vision loss in millions of patients.

Robert Johnson (fictitious name), a Sarasota-based senior, avoided losing his eyesight via early detection and treatment of AMD. During a dilated eye exam, we noticed an increased cluster of drusen in the back of his right eye. We conducted imaging tests that revealed significant swelling in the retina area and confirmed a budding form of wet AMD. Six shots of anti-VEGF within the same year stopped it in its tracks.

Mr. Johnson’s case is just one among the many successful treatments that the ophthalmologists at Shane Retina have had with eye injections. Research continues to search for a way to give injections less frequently or replace them with a topical drop.

A good number of patients treated with anti-VEGF have regained normal macular anatomy after consistent treatment. Vision improves as well. However, in patients who have already lost central vision, the medication may not bring back all the vision that was lost.

Most patients are surprised to learn that eye injections are not painful. The eye is thoroughly numbed with anesthetic drops before the injection, and many patients feel only mild pressure or slight awareness of the procedure.

The injection itself takes only a few seconds. You may notice brief pressure during the shot, but sharp pain is uncommon. Afterward, the eye can feel slightly scratchy or irritated for the rest of the day, similar to having a grain of sand in the eye. This sensation typically resolves within 24 hours.

Because the procedure is quick and performed under sterile conditions, most patients find it much easier than they expected. Many who were anxious before their first injection report that the experience is far less uncomfortable than anticipated.

Yes, intravitreal eye injections are considered very safe when performed by a trained retina specialist under sterile conditions. They have been used for over two decades and have prevented vision loss in millions of patients.

The procedure itself is quick and carefully controlled. The eye is cleaned with antiseptic and numbed before the injection to minimize discomfort and reduce the risk of infection.

As with any medical procedure, there are risks, but serious complications are rare. The most serious risk is infection inside the eye, known as endophthalmitis, which occurs in approximately 1 in several thousand injections. Other uncommon risks include retinal detachment or significant inflammation.

More commonly, patients may experience mild redness, irritation, temporary floaters, or slight blurriness for a day or two.

Overall, the risk of not treating conditions like wet macular degeneration is far greater than the risk associated with properly administered eye injections.

The number of eye injections you need depends on your specific condition, how severe it is, and how your eye responds to treatment.

Many patients start with a series of monthly injections to control swelling or abnormal blood vessel growth. Once the condition is stable, treatments are often spaced out over time using a “treat-and-extend” approach, where injections are given less frequently while still keeping the disease under control.

Some patients may need ongoing injections every few weeks to months, while others can go longer between treatments. Because retinal conditions are chronic, many people require long-term monitoring and periodic injections to maintain their vision.

Your retina specialist will adjust your treatment plan based on imaging and how your vision responds over time.

Most side effects of eye injections are mild and temporary. The most common reactions occur on the surface of the eye and typically resolve within a day or two.

Common side effects include:

• Redness on the white part of the eye
• Mild irritation or scratchy sensation
• Temporary blurring of vision
• Small floaters immediately after the injection
• A small surface blood spot where the injection was placed

These symptoms usually improve quickly and do not affect long-term vision.

Rare but serious complications can occur. These include infection inside the eye, known as endophthalmitis, significant inflammation, retinal detachment, or increased eye pressure. Severe pain, worsening vision, or light sensitivity after an injection should be reported immediately.

Although complications are uncommon, retina specialists use sterile technique and careful monitoring to minimize risk. For most patients, the benefits of preventing vision loss far outweigh the potential side effects.

Eye injections start working within days to weeks, but noticeable vision improvement may take several weeks, depending on the condition being treated.

For wet macular degeneration, diabetic macular edema, or retinal vein occlusion, anti-VEGF injections begin reducing retinal swelling shortly after administration. Some patients notice clearer vision within a week or two, while others may require multiple injections before meaningful improvement occurs.

In many cases, the first goal is stabilization rather than immediate improvement. Swelling decreases gradually, and vision may improve over the course of several treatments.

Your retina specialist monitors progress with imaging such as OCT scans to measure changes in retinal fluid and determine how well the medication is working. Treatment intervals may be adjusted based on response.

Whether you can drive after an eye injection depends on how your vision feels immediately afterward. Many patients are able to drive the same day, but some prefer to have someone else drive them home.

If your eyes were dilated before the injection, your vision may remain blurry or light-sensitive for several hours. In addition, it is common to experience temporary floaters or mild irritation after the procedure.

For safety, many retina specialists recommend arranging a driver for your first injection so you can see how your eyes respond. If your vision feels clear and comfortable after future injections, you may choose to drive yourself.

Your retina specialist can guide you based on your specific situation and visual stability.

You do not need strict bed rest after an eye injection, but it is reasonable to take it easy for the rest of the day.

Most patients can resume normal daily activities shortly after the procedure. However, your eye may feel mildly irritated or scratchy for several hours. Avoid rubbing your eye, and follow any post-injection instructions provided by your retina specialist.

It is generally safe to:

• Read or watch television
• Walk around normally
• Perform light household activities

For the first 24 hours, you may want to avoid:

• Heavy lifting
• Strenuous exercise
• Swimming or hot tubs
• Touching or rubbing the eye

If you experience severe pain, worsening vision, or increased light sensitivity, contact your retina specialist immediately.

Light activity is usually safe after an eye injection, but strenuous exercise should be avoided for about 24 hours.

You can typically walk, perform normal daily activities, and move around as usual the same day. However, it is best to avoid:

• Heavy lifting
• High-intensity workouts
• Straining or bending repeatedly
• Swimming or hot tubs

Your eye may feel mildly irritated or sensitive for the rest of the day, and avoiding strenuous activity reduces the risk of irritation or increased pressure.

Most patients can return to full exercise the following day unless your retina specialist advises otherwise.

Eye injections treat macular degeneration, but they do not cure it. If you stop receiving injections for wet macular degeneration, abnormal blood vessels can begin growing and leaking again.

When this happens, fluid and bleeding can return under the retina. Over weeks to months, this can lead to permanent central vision loss. In many cases, the vision that is lost after stopping treatment cannot be fully recovered, even if injections are restarted later.

That is why consistent treatment is important. Retina specialists often use a treat-and-extend approach to safely lengthen the interval between injections while keeping the disease under control. Stopping treatment entirely without medical guidance increases the risk of irreversible damage.

If scheduling, transportation, or discomfort is making treatment difficult, speak with your retina specialist. Treatment intervals can often be adjusted while still maintaining disease control.

Almost all medical insurances cover the diagnosis and treatment of eye conditions that require eye injections, but you are still subject to their copays, deductibles, and coinsurance.  Some insurances will have requirements for which drug is injected into your eye.  There are funds sponsored by the drug manufacturers that may help defray some of the cost of the medication.